1. The role of pharmacotherapy in assisting smoking cessation

   • W. Stephen Waring

   Review Article 25 July 2003 Pages: 351 - 356

2. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development

   • Mats Bergström
   • Anders Grahnén
   • Bengt Långström

   Review Article 22 August 2003 Pages: 357 - 366

   

3. Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration

   • Otto Mayer Jr
   • Jaroslav Šimon
   • Ivan Šubrt

   Pharmacodynamics 04 July 2003 Pages: 367 - 371

   

4. Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin

   • Giuseppe Gheno
   • Leonardo Cinetto
   • Massimo Randon

   Pharmacodynamics 08 July 2003 Pages: 373 - 377

5. Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production

   • Argirios E. Tsantes
   • Stergios T. Tassiopoulos
   • Dimitrios Loukopoulos

   Pharmacodynamics 05 August 2003 Pages: 379 - 383

   

6. Effect of CYP2D6*10 on pharmacokinetic variability of routinely administered metoprolol in middle-aged and elderly Japanese patients

   • Masato Taguchi
   • Takashi Nozawa
   • Yukiya Hashimoto

   Pharmacogenetics 12 August 2003 Pages: 385 - 388

   

7. Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations

   • Masahiro Sasaki
   • Yuichiro Tanaka
   • Rajvir Dahiya

   Pharmacogenetics 16 August 2003 Pages: 389 - 393

   

8. Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers

   • Masahiro Otani
   • Tsuyoshi Fukuda
   • Junichi Azuma

   Pharmacogenetics 23 August 2003 Pages: 395 - 399

   

9. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine

   • Jonatan D. Lindh
   • Anita Annas
   • Ayman AL-Shurbaji

   Pharmacokinetics and Disposition 25 July 2003 Pages: 401 - 406

   

10. Inhibitory effect of 5-fluorouracil on human cytochrome P₄₅₀ isoforms in human liver microsomes

    • Ji-Young Park
    • Kyoung-Ah Kim

    Pharmacokinetics and Disposition 05 August 2003 Pages: 407 - 409

    

11. Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years

    • Charles Oo
    • George Hill
    • Penelope Ward

    Pharmacokinetics and Disposition 09 August 2003 Pages: 411 - 415

    

12. Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers

    • Ayse Gelal
    • Hulya Guven
    • Neal L. Benowitz

    Pharmacogenetics and Disposition 14 August 2003 Pages: 417 - 422

    

13. Metabolism and elimination of quinine in healthy volunteers

    • Rajaa A. Mirghani
    • Urban Hellgren
    • Örjan Ericsson

    Pharmacokinetics and Disposition 12 August 2003 Pages: 423 - 427

    

14. Identification of human cytochrome P₄₅₀s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

    • Xue-Qing Li
    • Anders Björkman
    • Collen M. Masimirembwa

    Pharmacokinetics and Disposition 12 August 2003 Pages: 429 - 442

    

15. A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch

    • Joerg Hasford
    • Karl Olov Fagerstrom
    • Knut-Olav Haustein

    Pharmacoepidemiology and Prescription 25 July 2003 Pages: 443 - 447

16. Does the inhalation device affect the bronchodilatory dose response curve of salbutamol in asthma and chronic obstructive pulmonary disease patients?

    • Mariëlle E. A. C. Broeders
    • Johan Molema
    • Hans T. M. Folgering

    Pharmacoepidemiology and Prescription 12 August 2003 Pages: 449 - 455

    

17. Incidence and risk factors for nevirapine-associated rash

    • Monique M. R. de Maat
    • Rob ter Heine
    • Jos H. Beijnen

    Pharmacoepidemiology and Prescription 12 August 2003 Pages: 457 - 462

18. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents

    • Harald A. Nygaard
    • Mala Naik
    • Jørund Straand

    Pharmacoepidemiology and Prescription 12 August 2003 Pages: 463 - 469

19. Relationship between CYP3A activity and breast cancer susceptibility in Chinese Han women

    • Ping Huang
    • Bing Zhu
    • Hong-Hao Zhou

    Pharmacoepidemiology and Prescription 22 August 2003 Pages: 471 - 476

    

20. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland

    • Arja Helin-Salmivaara
    • Timo Klaukka
    • Risto Huupponen

    Pharmocoepidemiology and Prescription 21 August 2003 Pages: 477 - 482

    

21. Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand

    • Maria Johansson
    • Jason Hall
    • Murray Tilyard

    Pharmacoepidemiology and Prescription 23 August 2003 Pages: 483 - 487

    

22. Rofecoxib interaction with oral anticoagulant acenocoumarol

    • François Girardin
    • Michèle Siegenthaler
    • Jules Desmeules

    Letter to the Editors 25 July 2003 Pages: 489 - 490

23. Letter to the editor concerning Ufer et al.: Eur J Clin Pharmacol 58:779–783 (2003)

    • C. H. Gleiter
    • R. Bücheler
    • M. Schwab

    Letter to the Editor 26 July 2003 Pages: 491 - 491

24. Off-label paediatric prescribing in Stockholm (Sweden): a response to a letter to the editor

    • Mike Ufer
    • Ulf Bergman

    Letter to the Editors 26 July 2003 Pages: 493 - 494

25. Diffusion of new medicines into hospital practice

    • J. E. F. Zwart-van Rijkom
    • N. S. Breekveldt-Postma
    • A. C. G. Egberts

    Letter to the Editors 09 August 2003 Pages: 495 - 496